City National Bank’s VanEck Pharmaceutical ETF PPH Stock Holding History

City National Bank’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,900	Closed	-$344K	–	926
2014 Q1	$344K	Hold	5,900	–	–	﹤0.01%	627
2013 Q4	$313K	Buy	+5,900	New	+$299K	﹤0.01%	663

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return

Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

City National Bank's PPH Position: Q2 2014 in Review

City National Bank sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2014, closing a stake of 5,900 shares — an estimated $344K sold.

City National Bank first reported a position in PPH in Q4 2013 and held it in 2 quarters. The position peaked at $344K in Q1 2014. 54 funds tracked by Wall St. Rank hold PPH as of Q2 2014.

City National Bank reported no remaining VanEck Pharmaceutical ETF position as of Q2 2014 after selling out during the quarter.
City National Bank sold 5,900 VanEck Pharmaceutical ETF shares in Q2 2014, an estimated $344K.
City National Bank first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 2 quarters.
City National Bank's VanEck Pharmaceutical ETF position peaked at $344K in Q1 2014.
54 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2014.

Based on City National Bank's 13F filing for Q2 2014, filed 28 Jul 2014.